Skip to Main Content (Press Enter)

Logo UNIMORE
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze

UNI-FIND
Logo UNIMORE

|

UNI-FIND

unimore.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze
  1. Pubblicazioni

JOURNAL OF HEPATOLOGY

Rivista
Codice:
E092060
ISSN:
0168-8278
  • Dati Generali

Dati Generali

Pubblicazioni (176)

  • ascendente
  • decrescente
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis
Articolo
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial
Articolo
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX
Abstract
A RANDOMIZED TRIAL OF THE SAFETY AND HEPATIC HEMODYNAMIC EFFECTS OF INTRAVENOUS CONIVAPTAN IN EUVOLEMIC OR HYPERVOLEMIC CIRRHOTIC PATIENTS
Abstract
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY
Abstract
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease
Articolo
A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation
Articolo
A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
Articolo
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond
Abstract
A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (apo B-54.5)
Articolo
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon
Articolo
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY?
Abstract
ANTIBODIES TO HEPATITIS-C VIRUS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
Articolo
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY
Abstract
Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation
Articolo
Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis
Articolo
Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis
Articolo
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
Articolo
Analysis of factors involved in fibrosis progression among hepatitis C virus carriers with normal alanine aminotransferares. 41st Annual Meeting of the European Association for the Study of the Liver (EASL).Vienna, Austria, 26-30 Aprile 2006.
Articolo
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft
Articolo
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ?
Abstract
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome
Abstract
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis
Articolo
Baveno VII – Renewing consensus in portal hypertension
Articolo
Bed-rest-induced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintain 'compensation'?
Articolo
CONSERVED CORE PROTEIN SEQUENCES IN HEPATITIS-B VIRUS-INFECTED PATIENTS WITHOUT ANTI-HBC
Articolo
Cardiopulmonary hemodynamics and c-reactive protein as prognostic indicators in compensated and decompensated cirrhosis
Articolo
Cerebral Aspergillosis in a liver transplant recipient
Articolo
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD}
Articolo
Characteristics of hepatocellular carcinoma in Italy
Articolo
Characterization of ferroportin disease and SLC40A1-related hemochromatosis – Results from the EASL non-HFE registry
Articolo
Chicken or egg turned into head or belly
Articolo
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation
Abstract
Clinical staging systems for hepatocellular carcinoma: Comparison with estrogen receptor classification
Abstract
Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease
Articolo
Comment on the article “Age and liver transplantation”
Articolo
Complications following percutaneous liver biopsy: a multicenter retrospective study on 68.276 biopsies
Articolo
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))
Articolo
Corrigendum to ‘Baveno VII – Renewing consensus in portal hypertension’ [J Hepatol (2022) 959-974, (S0168827821022996), (10.1016/j.jhep.2021.12.022)]
Articolo
Corrigendum to “EASL Clinical Practice Guidelines on haemochromatosis” [J Hepatol 2022 (77) 479–502](S0168827822002112)(10.1016/j.jhep.2022.03.033)
Articolo
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019)
Articolo
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
Articolo
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods
Abstract
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS
Abstract
Detection of hepatitis B virus transcripts in patients with chronic liver disease.
Articolo
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B
Articolo
EASL Clinical Practice Guidelines on haemochromatosis
Articolo
EASL International Concensus Conference on Hepatitis B - 13-14 September, 2002 Geneva, Switzerland Consensus Statement (Long version)
Articolo
EASL International Consensus Conference on Haemochromatosis
Articolo
EASL International Consensus Conference on Hepatitis B: 13-14 September, 2002 Geneva, Switzerland - Consensus statement (short version)
Articolo
ECHO-COLOUR-DOPPLER CHARACTERIZATION OF CIRRHOTIC PATIENTS RESPONDERS AND NON-RESPONDERS TO NADOLOL AS PRIMARY PROPHYLAXIS
Abstract
EFFICACY AND SAFETY OF ENTECAVIR (ETV) PROPHYLAXIS IN INACTIVE HBV CARRIERS WHO UNDERWENT CHEMOTHERAPY FOR SOLID OR HAEMATOLOGICAL CANCER: INTERIM ANALYSIS OF A COHORT STUDY.
Abstract
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Articolo
Effect of acute administration of bile acids on fatty acid composition of biliary phosphatidylcholine in man
Articolo
Effect of liver cirrhosis on the systemic availability of naltrexone in humans
Articolo
Effect of ursodeoxycholic acid treatment on alanine aminotransferase and gamma-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial.
Articolo
Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial
Articolo
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients.
Abstract
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milano,Italia, 23-27 Aprile, 2008.
Articolo
Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis
Articolo
Epstein-Barr virus associated PTLD of donor origin in liver transplant recipients
Articolo
Erratum: Ferroportin disease: A systematic meta-analysis of clinical and molecular findings (Journal of Hepatology (2010) 53:5 (941-949))
Articolo
Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial.
Articolo
Expression of messenger RNA for liver functions following 70% and 90% hepatectomy
Articolo
F-actin dynamics regulates mammalian organ growth and cell fate maintenance
Articolo
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma
Articolo
Ferroportin disease: A systematic meta-analysis of clinical and molecular findings.
Articolo
Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy
Articolo
Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y
Articolo
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?
Articolo
From NAFLD in clinical practice to answers from guidelines.
Articolo
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence
Abstract
GLUCONEOGENIC SIGNALS DIRECTLY CONTROL IRON HOMEOSTASIS THROUGH HEPCIDIN
Abstract
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS)
Abstract
Gene expression of urea cycle enzymes following two-thirds partial hepatectomy in the rat.
Articolo
Genetic characterization of adult-onset cryptogenic cholestasis: a prospective multicentre study of 233 patients
Poster
Genetics in liver diseases
Articolo
HCV RNA IN SERUM OF ASYMPTOMATIC BLOOD-DONORS INVOLVED IN POSTTRANSFUSION HEPATITIS (PTH)
Articolo
HEPATITIS-C VIRUS TESTING IN PRIMARY BILIARY-CIRRHOSIS
Articolo
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE
Abstract
HIV-positive to HIV-positive liver transplantation: To be continued
Articolo
HUMAN BILIARY TREE STEM/PROGENITOR CELLS (hbTSCS) FROM PERIBILIARY GLANDS (PBGS) OF ADULT LIVER DISPLAY IMMUNOMODULATORY PROPERTIES THROUGH Fas/Fas LIGAND INDUCED T-CELL LYMPHOCYTE APOPTOSIS
Abstract
Hemochromatosis 1998: is one gene enough?
Articolo
Hemodynamic and renal effects of ascites apheresis, concentration and reinfusion in advanced cirrhosis.
Articolo
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma
Articolo
Hepatic steatosis and insulin resistance: Does etiology make a difference?
Articolo
Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma
Articolo
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
Articolo
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma.
Articolo
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
Articolo
Hepatitis C virus carriers with normal alanine aminotransferases: analysis of factors involved in fibrosis progression. 42nd Annual Meeting of the European Association for the Study of the Liver (EASL). Barcellona, Spagna, 11-15 aprile 2007.
Articolo
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir?
Articolo
Hepatitis C virus infection and chronic kidney disease: Time for reappraisal
Articolo
Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy.
Articolo
Hepatitis C virus, autoimmune liver diseases and cryoglobulinemic hepatitis
Articolo
Hepcidin in human iron disorders: therapeutic implications.
Articolo
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Articolo
IMPULSIONAL, POINT AND BIDIMENSIONAL SHEAR WAVE ELASTOMETRY FOR PORTAL HYPERTENSION: SAME STIFFNESS THRESHOLDS?
Abstract
INTERFERON-ALPHA PLUS RIBAVIRIN IN CHRONIC HEPATITIS C RESISTANT TO PREVIOUS INTERFERON-ALPHA COURSE: RESULTS OF A RANDOMIZED MULTICENTRE TRIAL
Articolo
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS?
Abstract
Impact of MELD 30-allocation policy on liver transplant outcomes in Italy
Articolo
Improving outcomes of in situ split liver transplantation in Italy over the last 25 years
Articolo
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant
Articolo
Inclusive healthcare in light of the new MASLD guidelines: Should people living with HIV be screened for liver fibrosis?
Articolo
Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis.
Articolo
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach.
Articolo
Interferon-alpha increases prostaglandin E2 production by cultured liver biopsy in patients with chronic viral hepatitis: can non-steroidal anti-inflammatory drugs improve the therapeutic response to interferon?
Articolo
Interindividual variability of the number connection test
Articolo
Iron in NASH, chronic liver diseases and HCC: How much iron is too much?
Articolo
Iron, friend or foe? "Freedom" makes the difference
Articolo
Iron, oxidative stress and liver fibrogenesis.
Articolo
Juvenile hemochromatosis
Articolo
LAMIVUDINE TREATMENT FOR ACUTE HEPATITIS B AFTER LIVER TRANSPLANTATION
Articolo
LIVER KIDNEY TRANSPLANTATION IN TYPE 1 PRIMARY OXALURIA:DESCRIPTIONAND COMMENTS ON A CASE.
Articolo
LOW MOLECULAR WEIGHT HEPARIN TREATMENT DOES NOT INCREASE THE RISK OF BLEEDING AFTER PROPHYLACTIC ENDOSCOPIC VARICEAL BAND LIGATION IN PATIENTS WITH CIRRHOSIS
Abstract
Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure
Articolo
Liver Stiffness improvement in subjects with advanced chronic hepatitis C treated with direct antiviral agents
Abstract
Liver Stiffness measurments using Fibroscan after three months of IFN-based antiviral therapy is unlikely to predict viral response in cirrhotic patients
Abstract
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool
Articolo
Long-term outcomes after hypothermic oxygenated machine perfusion and transplantation of 1,202 donor livers in a real-world setting (HOPE-REAL study)
Articolo
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS.
Abstract
MUTATIONAL ANALYSIS OF THE HBV PRE-CORE/CORE GENE IN HBV/HCV-RELATED HEPATOCELLULAR CARCINOMA
Abstract
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients
Articolo
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation
Abstract
Mechanisms of iron hepatotoxicity
Articolo
Modulation of the synthesis of apolipoproteins in rat hepatoma cells.
Articolo
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis
Articolo
No inflammation? No cancer! Clear HBV early and live happily.
Articolo
Non alcoholic Fatty liver disease ( NAFLD): and insulin reistance:does PC-1 K121Q play a role?
Abstract
Non-invasive assessment of hepatic iron overload: are we finally there?
Articolo
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE
Abstract
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis.
Articolo
PEGYLATED INTERFERON PLUS RIBAVIRIN FOR THE TREATMENT OF RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION
Abstract
PROCALCITONIN IS THE BEST DIAGNOSTIC AND PROGNOSTIC MARKER OF SEPSIS IN DECOMPENSATED CIRRHOTIC PATIENTS
Abstract
PROGRESSIVE ALTERATIONS IN SYSTEMIC AND CARDIOPULMONARY HEMODYNAMICS OCCUR IN PATIENTS WITH CIRRHOSIS AND PREDICT DEATH IN DECOMPENSATED CIRRHOSIS
Abstract
Pediatric gallstone disease in familial hypobetalipoproteinemia
Articolo
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome
Articolo
Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment
Articolo
Prediciting the natural history of patients with epatitis C and persistently normal transaminases: a longitudinal long term study with dual biopsies. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL).
Articolo
Prediciting the natural history of patients with epatitis C and persistently normal transaminases: a longitudinal long term study with dual biopsies. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milano, Italia, 23-27 Aprile, 2008.
Articolo
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV
Articolo
Primary biliary cholangitis associated with SARS-CoV-2 infection
Articolo
Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders
Articolo
Reply to correspondence concerning: "Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection"
Articolo
Reply to: “Ceruloplasmin variants might have different effects in different iron overload disorders”
Articolo
Reply to: “Does encephalopathy with early onset after TIPS impact on mortality?”
Articolo
Reply to: “Hepatic encephalopathy and survival after transjugular intra-hepatic portosystemic shunt: Do spontaneous portosystemic shunts matter?”
Articolo
Reply to: “It takes two “eyes” to see in depth”
Articolo
Reply to: “Post-TIPS OHE: Are we really making a mountain out of a molehill?”
Articolo
Reply to: “Relationship of hyperdynamic circulation and cardiodynamic states in cirrhosis”
Articolo
Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection
Articolo
Serum levels of naltrexone and 6-beta-naltrexol after oral naltrexone in patients with liver cirrhosis
Abstract
Solving hemochromatosis with knock-out mice
Articolo
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients
Abstract
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study
Articolo
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
Articolo
Strategies for liver support: From stem cells to xenotransplantation
Articolo
Suprression of in vivo bile acid synthesis, but not of in vitro cholesterol 7 alpha-hydroxylase expression, by biliary obstruction in humans
Articolo
Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma
Articolo
Sustained virologic response rates with telaprevir by response after 4weeks of lead-in therapy in patients with prior treatment failure
Articolo
Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis
Articolo
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS.
Abstract
THU-086 - The role of spleen stiffness measurement as predictor of hepatocellular carcinoma recurrence after curative resection in cirrhotic patients
Abstract
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens
Abstract
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients
Abstract
The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells
Articolo
The epidemiology of hepatitis delta infection in Italy
Articolo
The relationship between age and fat infiltration in liver and muscle
Articolo
The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression
Articolo
Thrombophilic genetic risk factors for liver fibrosis: To screen or not to screen?
Articolo
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS
Contributo in Atti di convegno
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis
Articolo
Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats
Abstract
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
Articolo
When and how to treat acute hepatitis C?
Articolo
non alcoholic fatty liver disease ( NAFLD) :is femlae sex safer?
Abstract
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} di {itemsNumber}
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0